"Acetylglucosamine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The N-acetyl derivative of glucosamine.
| Descriptor ID |
D000117
|
| MeSH Number(s) |
D09.067.342.531.050
|
| Concept/Terms |
Acetylglucosamine- Acetylglucosamine
- 2-Acetamido-2-Deoxyglucose
- 2 Acetamido 2 Deoxyglucose
- N-Acetyl-D-Glucosamine
- N Acetyl D Glucosamine
- 2-Acetamido-2-Deoxy-D-Glucose
- 2 Acetamido 2 Deoxy D Glucose
|
Below are MeSH descriptors whose meaning is more general than "Acetylglucosamine".
Below are MeSH descriptors whose meaning is more specific than "Acetylglucosamine".
This graph shows the total number of publications written about "Acetylglucosamine" by people in this website by year, and whether "Acetylglucosamine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 1 | 0 | 1 |
| 2003 | 1 | 1 | 2 |
| 2004 | 0 | 1 | 1 |
| 2005 | 0 | 1 | 1 |
| 2006 | 1 | 0 | 1 |
| 2013 | 1 | 0 | 1 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Acetylglucosamine" by people in Profiles.
-
Li S, You X, Rani A, ?zcan E, Sela DA. Bifidobacterium infantis utilizes N-acetylglucosamine-containing human milk oligosaccharides as a nitrogen source. Gut Microbes. 2023 12; 15(2):2244721.
-
Cywes-Bentley C, Skurnik D, Zaidi T, Roux D, Deoliveira RB, Garrett WS, Lu X, O'Malley J, Kinzel K, Zaidi T, Rey A, Perrin C, Fichorova RN, Kayatani AK, Maira-Litr?n T, Gening ML, Tsvetkov YE, Nifantiev NE, Bakaletz LO, Pelton SI, Golenbock DT, Pier GB. Antibody to a conserved antigenic target is protective against diverse prokaryotic and eukaryotic pathogens. Proc Natl Acad Sci U S A. 2013 Jun 11; 110(24):E2209-18.
-
Uddin N, Hoessli DC, Butt A, Kaleem A, Iqbal Z, Afzal I, Zamani Z, Shakoori AR. O-GlcNAc modification of the anti-malarial vaccine candidate PfAMA1: in silico-defined structural changes and potential to generate a better vaccine. Mol Biol Rep. 2012 Apr; 39(4):4663-72.
-
Din N, Ahmad I, Ul Haq I, Elahi S, Hoessli DC, Shakoori AR. The function of GluR1 and GluR2 in cerebellar and hippocampal LTP and LTD is regulated by interplay of phosphorylation and O-GlcNAc modification. J Cell Biochem. 2010 Feb 15; 109(3):585-97.
-
Kaleem A, Ahmad I, Walker-Nasir E, Hoessli DC, Shakoori AR. Effect on the Ras/Raf signaling pathway of post-translational modifications of neurofibromin: in silico study of protein modification responsible for regulatory pathways. J Cell Biochem. 2009 Nov 01; 108(4):816-24.
-
Ahmad I, Khan TS, Hoessli DC, Walker-Nasir E, Kaleem A, Shakoori AR. In silico modulation of HMGN-1 binding to histones and gene expression by interplay of phosphorylation and O-GlcNAc modification. Protein Pept Lett. 2008; 15(2):193-9.
-
Kelly-Quintos C, Cavacini LA, Posner MR, Goldmann D, Pier GB. Characterization of the opsonic and protective activity against Staphylococcus aureus of fully human monoclonal antibodies specific for the bacterial surface polysaccharide poly-N-acetylglucosamine. Infect Immun. 2006 May; 74(5):2742-50.
-
Uchimura K, Gauguet JM, Singer MS, Tsay D, Kannagi R, Muramatsu T, von Andrian UH, Rosen SD. A major class of L-selectin ligands is eliminated in mice deficient in two sulfotransferases expressed in high endothelial venules. Nat Immunol. 2005 Nov; 6(11):1105-13.
-
Arcaro KF, Wang J, Otis CN, Zuckerman BM. Beta-galactosidase and alpha-mannosidase inhibit formation of multicellular nodules in breast cancer cell cultures. Anticancer Res. 2004 Jan-Feb; 24(1):139-44.
-
Bulik DA, Olczak M, Lucero HA, Osmond BC, Robbins PW, Specht CA. Chitin synthesis in Saccharomyces cerevisiae in response to supplementation of growth medium with glucosamine and cell wall stress. Eukaryot Cell. 2003 Oct; 2(5):886-900.